Raymond James Financial »

Lineage Cell Therapeutics In shares owned by Raymond James Financial

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Raymond James Financial from 13F filings

Historical chart of Raymond James Financial investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by Raymond James Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by Raymond James Financial

Quarter filed Position value Share count Share price at filing
2025-09-30 $153k 90k 1.69
2025-06-30 $63k 69k 0.91
2025-03-31 $13k 29k 0.45
2024-12-31 $17k 34k 0.50